Implement Consulting Group

Your patients have already made up their minds before they see a doctor. But did you have a say? Between AI and social media, patients decide what's wrong, whether to seek care, and what to ask for, all on their own. Those decisions determine whether patients get diagnosed and how soon they start treatment. Yet pharma companies are rarely part of them. Patient activation changes that. Our new whitepaper shows how.

Have you invested in disease awareness over the past few years? Then you've already done the hard part. Patients know the condition exists. They recognise the symptoms. Many of them have probably wondered if it applies to them. But recognising a symptom isn't the same as booking an appointment. And without a clear next step, most people stop there. Patient activation builds on the awareness you've already created and turns it into action. Our new whitepaper shows how to get started.

What would it mean for your business if undiagnosed patients actually went to the doctor? In some disease areas, a large part of the delay between first symptom and treatment happens before the patient ever sees a doctor. It isn't driven by waiting lists or clinical pathways but by patients who explain away their symptoms or don't think they're worth a doctor's time. Shorten that delay, and patients start treatment sooner and stay on it longer. And patient activation can help you do that. Our new whitepaper shows how other pharma companies are doing it.

Your patients have often made up their minds before they see a doctor. If you're not part of that conversation, you're missing one of the biggest commercial opportunities in pharma right now. Patients now search, scroll and ask AI assistants before they ever book an appointment with a doctor. Along the way, they decide what might be wrong, whether it's worth seeing a doctor, and what to ask for when they get there. Those decisions matter for both patients and your business. A patient who puts off seeing a doctor starts treatment late. A patient who never goes doesn't start at all. Pharma companies have the disease knowledge to be genuinely useful at those moments, yet they are rarely part of them. Patient activation is how you become part of it. It picks up where disease awareness stops: instead of only informing patients, it helps them take a specific next step, like completing a self-test or booking an appointment with their doctor. Because patient activation leads to concrete actions, it's one of the few patient-facing activities where you can see what your investment actually delivers. In our new whitepaper, we explain what patient activation is, how to tell whether it fits your therapy area, and what we've learned from helping pharma companies get started. Link in the comments.

22,000 projects say the same thing: the plan isn't the problem. It's you. Most transformations fail because change collides with human behaviour. Join our "Why transformations fail" event on 5 November to hear insights from Implement and commercial leaders from Essity.

22,000 projects say the same thing: the plan isn't the problem. It's you. Most transformations fail because change collides with human behaviour. Join our "Why transformations fail" event on 5 November to hear insights from Implement and commercial leaders from Essity.